What Defines a Value Stock?
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:
- RAPT Therapeutics RAPT - P/E: 0.75
- Satsuma Pharmaceuticals STSA - P/E: 2.65
- Triple-S Management GTS - P/E: 9.26
- Greenlane Holdings GNLN - P/E: 6.15
- Jaguar Health JAGX - P/E: 0.21
Most recently, RAPT Therapeutics reported earnings per share at -0.6, whereas in Q2 earnings per share sat at -0.51. RAPT Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Most recently, Satsuma Pharmaceuticals reported earnings per share at -0.69, whereas in Q2 earnings per share sat at -0.65. Satsuma Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Most recently, Triple-S Management reported earnings per share at 0.61, whereas in Q2 earnings per share sat at 1.76. Triple-S Management does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Greenlane Holdings's earnings per share for Q3 sits at -0.35, whereas in Q2, they were at -0.46. Greenlane Holdings does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Jaguar Health has reported Q3 earnings per share at -0.21, which has increased by 52.27% compared to Q2, which was -0.44. Jaguar Health does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.